Can the placebo be the cure?
Enserink
M
M
D000928:Antidepressive Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D000077608:Aprepitant; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D015201:Meta-Analysis as Topic; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D010919:Placebos / Q000627:therapeutic use; D011600:Psychopharmacology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013373:Substance P / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000077608:Aprepitant; D008996:Monoamine Oxidase Inhibitors; D009025:Morpholines; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors; D013373:Substance P